Inspire Medical Systems, Inc. (NYSE:INSP) Given Average Rating of “Moderate Buy” by Analysts

Inspire Medical Systems, Inc. (NYSE:INSP) has been given an average rating of “Moderate Buy” by the eleven ratings firms that are presently covering the stock, MarketBeat Ratings reports. Three research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. The average twelve-month price objective among brokerages that have issued ratings on the stock in the last year is $228.82.

Several research analysts recently weighed in on the stock. Morgan Stanley cut their target price on shares of Inspire Medical Systems from $230.00 to $220.00 and set an “overweight” rating for the company in a research note on Tuesday. Stifel Nicolaus cut their price objective on shares of Inspire Medical Systems from $200.00 to $190.00 and set a “hold” rating for the company in a research report on Tuesday, January 21st. Piper Sandler decreased their target price on shares of Inspire Medical Systems from $260.00 to $233.00 and set an “overweight” rating on the stock in a research report on Monday. Wells Fargo & Company lowered their target price on shares of Inspire Medical Systems from $198.00 to $195.00 and set an “equal weight” rating for the company in a research note on Tuesday. Finally, KeyCorp reissued an “overweight” rating and set a $234.00 price target (down previously from $236.00) on shares of Inspire Medical Systems in a research note on Friday, January 24th.

Institutional Inflows and Outflows

Several large investors have recently made changes to their positions in INSP. First Horizon Advisors Inc. lifted its stake in shares of Inspire Medical Systems by 885.7% in the 4th quarter. First Horizon Advisors Inc. now owns 138 shares of the company’s stock valued at $26,000 after purchasing an additional 124 shares in the last quarter. True Wealth Design LLC purchased a new stake in Inspire Medical Systems during the third quarter worth approximately $30,000. Farther Finance Advisors LLC increased its position in shares of Inspire Medical Systems by 1,158.3% in the third quarter. Farther Finance Advisors LLC now owns 151 shares of the company’s stock worth $32,000 after acquiring an additional 139 shares in the last quarter. Huntington National Bank lifted its holdings in shares of Inspire Medical Systems by 228.3% during the 4th quarter. Huntington National Bank now owns 174 shares of the company’s stock valued at $32,000 after acquiring an additional 121 shares in the last quarter. Finally, Harbour Investments Inc. boosted its position in Inspire Medical Systems by 101.0% during the 4th quarter. Harbour Investments Inc. now owns 197 shares of the company’s stock worth $37,000 after purchasing an additional 99 shares during the period. 94.91% of the stock is owned by hedge funds and other institutional investors.

Inspire Medical Systems Price Performance

Shares of INSP opened at $187.17 on Friday. Inspire Medical Systems has a 1-year low of $123.00 and a 1-year high of $257.40. The stock has a market cap of $5.61 billion, a price-to-earnings ratio of 174.93 and a beta of 1.32. The firm has a 50 day simple moving average of $189.39 and a 200-day simple moving average of $191.39.

Inspire Medical Systems (NYSE:INSP) last released its quarterly earnings results on Monday, February 10th. The company reported $1.15 earnings per share for the quarter, topping the consensus estimate of $0.74 by $0.41. Inspire Medical Systems had a return on equity of 5.30% and a net margin of 4.37%. On average, equities analysts expect that Inspire Medical Systems will post 1.33 earnings per share for the current fiscal year.

About Inspire Medical Systems

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.